How Much Can Abbott's Price Gain If FreeStyle Libre Gets 30% of The Blood Glucose Monitoring Market?

Forbes - 20 Dec 2018 21:45

Abbott Labs' (NYSE:ABT) stock price could gain over 10% if its FreeStyle Libre system captures a 30% share of the blood glucose monitoring market by 2020, according to our estimates. FreeStyle Libre has seen strong acceptance in recent quarters. It is the only continuous glucose monitoring device...